EcoDrugPlus

Kinesin Family Member 11

Ensembl ID : ENSOCUG00000016706
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSOCUG00000017493
Gene Symbol: KIF5B
2 Cross references
281 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSOCUG00000005535
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSOCUG00000026176
Gene Symbol: LTB4R
2 Cross references
140 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSOCUG00000023320
Gene Symbol: LTB4R2
2 Cross references
236 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSOCUG00000001164
Gene Symbol: KDM1A
2 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSOCUG00000014596
Gene Symbol: LOXL2
2 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSOCUG00000024383
Gene Symbol: MIF
3 Cross references
218 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSOCUG00000009360
Gene Symbol: MST1R
2 Cross references
266 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSOCUG00000008177
Gene Symbol: MGAM
2 Cross references
312 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSOCUG00000017958
Gene Symbol: MMP1
3 Cross references
352 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSOCUG00000008303
Gene Symbol: MMP12
3 Cross references
550 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).